US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
How Americans' changing views on health paved the way for RFK Jr.
The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...
Why Merck & Co., Inc. (MRK) is Declining
We recently published an article titled Why These 10 Dividend Stocks Are Declining? In this article, we are going to take a ...
Merck stock price target cut to $115 at Guggenheim
Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...
ELLE Canada20h
Former NFL Star Laurent Duvernay-Tardif Redefines Success Beyond Sports
Tardif—who’s now involved in public health and the educational success of young people through his namesake foundation—opens ...
Health companies return $2.6 trillion to shareholders over time amid rising medical costs
Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...
Pharmaceutical Technology21h
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...